220 related articles for article (PubMed ID: 26195258)
1. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?
Desjardins A
Nat Rev Neurol; 2015 Aug; 11(8):429-30. PubMed ID: 26195258
[No Abstract] [Full Text] [Related]
2. Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.
Kovic B; Xie F
J Clin Oncol; 2015 Jul; 33(20):2296-302. PubMed ID: 26014296
[TBL] [Abstract][Full Text] [Related]
3. Reply to T.J. Kruser et al.
Chinot OL; Taphoorn MJ; Bais C; Bourgon R; Phillips HS; Abrey LE; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Cloughesy T
J Clin Oncol; 2016 Apr; 34(11):1282-3. PubMed ID: 26884575
[No Abstract] [Full Text] [Related]
4. Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient?
Kruser TJ; Mehta MP; Kozak KR
J Clin Oncol; 2016 Apr; 34(11):1281-2. PubMed ID: 26884565
[No Abstract] [Full Text] [Related]
5. Avastin: more questions than answers. .
Desjardins A; Sampson JH
J Neurosurg; 2012 Feb; 116(2):336-40; discussion 340. PubMed ID: 22035270
[No Abstract] [Full Text] [Related]
6. Similar Trials With Differing Outcomes: Reconciliation in Glioblastoma.
Chamberlain MC
J Clin Oncol; 2016 Jan; 34(3):291-2. PubMed ID: 26628477
[No Abstract] [Full Text] [Related]
7. Reply to M.C. Chamberlain.
Taphoorn MJ
J Clin Oncol; 2016 Jan; 34(3):292. PubMed ID: 26628468
[No Abstract] [Full Text] [Related]
8. Taming glioblastoma by targeting angiogenesis: 3 years later.
Wong ET; Brem S
J Clin Oncol; 2011 Jan; 29(2):124-6. PubMed ID: 21135277
[No Abstract] [Full Text] [Related]
9. [Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions].
Lebrun-Frenay C
Rev Neurol (Paris); 2014 Apr; 170(4):235-6. PubMed ID: 24776742
[No Abstract] [Full Text] [Related]
10. Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.
Taphoorn MJ; Henriksson R; Bottomley A; Cloughesy T; Wick W; Mason WP; Saran F; Nishikawa R; Hilton M; Theodore-Oklota C; Ravelo A; Chinot OL
J Clin Oncol; 2015 Jul; 33(19):2166-75. PubMed ID: 26014298
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab for glioblastoma multiforme after traumatic subarachnoid hemorrhage.
Lukas RV; Goldenberg F; Nicholas MK
J Clin Neurosci; 2012 Sep; 19(9):1310-1. PubMed ID: 22721885
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
[TBL] [Abstract][Full Text] [Related]
13. Can We Predict Bevacizumab Responders in Patients With Glioblastoma?
Mayer TM
J Clin Oncol; 2015 Sep; 33(25):2721-2. PubMed ID: 26195699
[No Abstract] [Full Text] [Related]
14. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
[TBL] [Abstract][Full Text] [Related]
15. Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma.
Malkki H
Nat Rev Neurol; 2014 Apr; 10(4):179. PubMed ID: 24638136
[No Abstract] [Full Text] [Related]
16. Targeted therapies: Further delineating bevacizumab's response spectrum.
Reardon DA; Wen PY
Nat Rev Clin Oncol; 2014 May; 11(5):243-4. PubMed ID: 24710578
[No Abstract] [Full Text] [Related]
17. [Survival benefit from the addition of bevacizumab to first-line radiochemotherapy for the treatment of proneural glioblastoma?].
Seidel C; Kortmann RD
Strahlenther Onkol; 2016 Jan; 192(1):65-6. PubMed ID: 26560703
[No Abstract] [Full Text] [Related]
18. Bevacizumab in glioblastoma--still much to learn.
Fine HA
N Engl J Med; 2014 Feb; 370(8):764-5. PubMed ID: 24552324
[No Abstract] [Full Text] [Related]
19. Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital.
Diebold G; Ducray F; Henaine AM; Frappaz D; Guyotat J; Cartalat-Carel S; Breant V; Fouquet A; Aulagner G; Honnorat J; Armoiry X
J Clin Pharm Ther; 2014 Dec; 39(6):642-8. PubMed ID: 25164371
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab for newly diagnosed glioblastoma.
Chinot OL; Wick W; Cloughesy T
N Engl J Med; 2014 May; 370(21):2049. PubMed ID: 24860870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
